2014～2016年海军机关门诊部降糖药物应用分析  

Analysis on Application of Anti-diabetic Drugs in Naval Authorities Clinic during 2014-2016

作　　者：王晓晖 白雪[2] WANG Xiao-hui;BAI Xue(Department of Pharmacy,Naval Authorities Clinic,Beijing 100841,China;College of Pharmaceutical Science,Zhejiang Chinese Medical University,Hangzhou 310053,China)

机构地区：[1]海军机关门诊部药剂科,北京100841 [2]浙江中医药大学药学院,浙江杭州310053

出　　处：《食品与药品》2018年第5期370-374,共5页Food and Drug

摘　　要：目的评价海军机关门诊部降糖药物应用情况,为基层医院合理使用降糖药物提供依据。方法采用金额排序和限定日剂量分析方法,对门诊部2014~2016年降糖药物的主要品种、用药频度(DDDs)、B/A,限定日费用(DDC)等进行统计分析。结果降糖药销售金额排序前3位是α-糖苷酶抑制剂、双胍类和胰岛素。口服降糖药的使用以α-糖苷酶抑制剂、双胍类和磺脲类为主,其中阿卡波糖和二甲双胍的销售金额排序和用药频度排序均居前2位。胰岛素中预混胰岛素30R的用药金额和DDDs排序始终位于第1。结论门诊部2014~2016年降糖药物使用情况较合理,阿卡波糖和二甲双胍为临床首选药物。Objective To comment the use of anti-diabetic drugs in naval authorities clinic, in order to provide evidence for the rational use of anti-diabetic drugs in the basic hospitals. Methods Amount ranking and defined daily dose （DDD） were adopted to analyze the category, DDDs, B/A and defined daily cost （DDC） of anti-diabetic drugs in our clinic during 2014-2016. Results The three anti-diabetic drugs of highest sales amount were alpha glycosidase inhibitors, biguanides and insulin. The oral anti-diabetics used mainly were α-glucosidase inhibitors, sulfonylureas and biguanides, of which the acarbose and metformin ranked top 2 in both sales amount and DDDs. Biphasic human insulin 30R was the insulin ranked top 1 in both sales amount and DDDs. Conclusion The application of oral anti-diabetic drugs in our clinic is basically rational, and acarbose and metformin are preferred in clinic.

关 键 词：降糖药物 用药分析 用药频度 限定日费用 排序比 

分 类 号：R977.15[医药卫生—药品]